Sign In | 0 items - USD $0.00 | Search | 简体中文

Products Content

Blog Tag: Parkinson's disease

Akt Signaling

Akt Signaling, Cell Growth and Survival

Brenda Knox | October 19th, 2021 | Scientific Review

Characterizing Pathogenic Protein Aggregates for Utilization as Molecular Tools to Accelerate Neurodegenerative Disease Research

Webinar: Accelerating Neurodegenerative Disease Research with Pathogenic Protein Aggregates

Brenda Knox | September 14th, 2021 | Webinar

Why target Alpha Synuclein Monomers?

Alpha Synuclein Monomers: Key Players in Neurodegeneration

Brenda Knox | June 10th, 2021 | Scientific Review

N terminal acetylated alpha synuclein monomers and fibrils for neurodegenerative disease research

N-terminal Acetylated Alpha Synuclein in Parkinson’s Disease

StressMarq Biosciences | May 13th, 2021 | Scientific Review

DENND4C and the Retromer Complex in Neurodegenerative Diseases

DENND4C and the Retromer Complex in Neurodegenerative Diseases

Patricia Thomson | January 21st, 2021 | Scientific Review

Alpha synuclein SUMOylation: A Novel Therapeutic Target for Parkinson's Disease

Alpha Synuclein SUMOylation: A Novel Therapeutic Target for Parkinson’s Disease

Christina Korgiopoulou | October 2nd, 2020 |

Podcast: Gene Expression in Parkinson’s Disease with Alessia Sciortino

Patricia Thomson | September 23rd, 2020 | Podcasts

Parkinson's Disease Therapies Targeting Alpha Synuclein

Parkinson’s Disease Therapies Targeting Alpha Synuclein

Christina Korgiopoulou | September 9th, 2020 | Scientific Review

Types of Alpha Synuclein Fibrillar Constructs

Types of Alpha Synuclein Fibrillar Constructs

Christina Korgiopoulou | August 10th, 2020 | Scientific Review

Alpha synuclein oligomers and their role in synucleinopathies

Alpha Synuclein Oligomers and their Role in Synucleinopathies

Christina Korgiopoulou | July 22nd, 2020 | Scientific Review